Millipore Sigma Vibrant Logo

324831 EGF, Human, Recombinant, E. coli

EGF, Human, Recombinant, E. coli: Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: Epidermal Growth Factor, Human, Recombinant, E. coli

View Products on Sigmaaldrich.com
324831
Ver precios y disponibilidad

Descripción

Replacement Information

Tabla espec. clave

Purity
≥95% by SDS-PAGE

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
324831-200UG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 200 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewRecombinant, human epidermal growth factor (54 amino acids) expressed in E. coli. Identical to human EGF except for an additional N-terminal methionine. Human EGF is 70% homologous to mouse EGF and has been shown to have similar biological activity. Mitogenic for a wide range of ectoderm- and endoderm-derived cells from tissue such as breast, cornea, epidermis, dermis, liver, pancreas, nerve, amnion, and adrenal medulla. Acts as a survival factor in preventing apoptosis.
      Catalogue Number324831
      Brand Family Calbiochem®
      SynonymsEpidermal Growth Factor, Human, Recombinant, E. coli
      References
      ReferencesMerlo, G.R., et al. 1995. J. Cell Biol. 128, 1185.
      Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147.
      Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415.
      Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69.
      Downward, J., et al. 1984. Nature 311, 483.
      Gray, A., et al. 1983. Nature 303, 722.
      Scott, J., et al. 1983. Science 221, 236.
      Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302.
      Product Information
      CAS number62229-50-9
      FormSolid
      FormulationLyophilized from sterile-filtered PBS.
      Quality LevelMQ100
      Applications
      Biological Information
      Biological activityED₅₀ = 100-400 pg/ml as measured by its ability to stimulate the ³H-thymidine incorporation in an EGF-responsive mouse fibroblast cell line, Balb/3T3.
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: <1.0 EU/μg EGF
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSKB4518000
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C or -70°C) for long term storage or refrigerate (4°C) for short-term storage. Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C or -70°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      324831-200UG 04055977216189

      Documentation

      Licencias necesarias

      Título
      CARTA DE USO GENERAL 2016
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      EGF, Human, Recombinant, E. coli Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      EGF, Human, Recombinant, E. coli Certificados de análisis

      CargoNúmero de lote
      324831

      Referencias bibliográficas

      Visión general referencias
      Merlo, G.R., et al. 1995. J. Cell Biol. 128, 1185.
      Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147.
      Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415.
      Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69.
      Downward, J., et al. 1984. Nature 311, 483.
      Gray, A., et al. 1983. Nature 303, 722.
      Scott, J., et al. 1983. Science 221, 236.
      Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-May-2008 RFH
      SynonymsEpidermal Growth Factor, Human, Recombinant, E. coli
      DescriptionRecombinant, human epidermal growth factor (54 amino acids) expressed in E. coli. Identical to native human EGF except for an additional N-terminal methionine. Human EGF is 70% homologous to mouse EGF and has been shown to have similar biological activity. Mitogenic for a wide range of ectoderm- and endoderm-derived cells from tissue such as breast, cornea, epidermis, dermis, liver, pancreas, nerve, amnion, and adrenal medulla. Binding of EGF to its 170 kDa transmembrane receptor results in dimerization of the receptor, activation of the intrinsic receptor tyrosine kinase, and initiation of the complex signal transduction cascade that leads to cell proliferation and/or differentiation. Acts as a survival factor in preventing apoptosis.
      FormSolid
      FormulationLyophilized from sterile-filtered PBS.
      CAS number62229-50-9
      RTECSKB4518000
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: <1.0 EU/μg EGF
      Biological activityED₅₀ = 100-400 pg/ml as measured by its ability to stimulate the ³H-thymidine incorporation in an EGF-responsive mouse fibroblast cell line, Balb/3T3.
      SolubilityReconstitute to a concentration of ≥10 µg/ml in 10 mM acetic acid containing ≥0.1% HSA or BSA.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C or -70°C) for long term storage or refrigerate (4°C) for short-term storage. Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -20°C or -70°C.
      Toxicity Standard Handling
      Merck USA index14, 3527
      ReferencesMerlo, G.R., et al. 1995. J. Cell Biol. 128, 1185.
      Yoshida, T., et al. 1993. Brain Res. Dev. 76, 147.
      Rubin, J.S., et al. 1991. Proc. Natl. Acad. Sci. USA 88, 415.
      Carpenter, G., and Wahl, M.I. 1990. In The Epidermal Growth Factor Family in Peptide Growth Factors and Their Receptors (Sporn, M.B., and Roberts, A.B., eds.) Springer-Verlag, New York, p 69.
      Downward, J., et al. 1984. Nature 311, 483.
      Gray, A., et al. 1983. Nature 303, 722.
      Scott, J., et al. 1983. Science 221, 236.
      Cohen, S. 1960. Proc. Natl. Acad. Sci. USA 46, 302.